Re-Post with added information
$Eton Pharmaceutical(ETON.US$ Eton Pharmaceuticals' ET-400 Protect Candidate Approved for US Patent
MT Newswires· 2 mins ago
Eton Pharmaceuticals (ETON) on Wednesday said it received a US patent protecting the intellectual property supporting the drug maker's ET-400 product candidate through 2043.
If successful, ET-400 will be included in FDA catalog of Approved Drug Products with Therapeutic Equivalence Evaluations, more commonly known as the Orange Book.
The company also has additional applications pending before the US Patent and Trademark Office for ET-400.
MT Newswires· 2 mins ago
Eton Pharmaceuticals (ETON) on Wednesday said it received a US patent protecting the intellectual property supporting the drug maker's ET-400 product candidate through 2043.
If successful, ET-400 will be included in FDA catalog of Approved Drug Products with Therapeutic Equivalence Evaluations, more commonly known as the Orange Book.
The company also has additional applications pending before the US Patent and Trademark Office for ET-400.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
